{"id":71470,"date":"2026-05-20T11:55:00","date_gmt":"2026-05-20T11:55:00","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=71470"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"l-glutathione-reduced-gsh","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/l-glutathione-reduced-gsh\/","title":{"rendered":"L-Glutathione (Reduced \/ GSH) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 \u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08GSH\uff09\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>L-\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08\u9084\u5143\u578b; GSH\uff09<\/strong> \u306f\u3001\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308b\u03b3-\u30b0\u30eb\u30bf\u30df\u30eb-\u30b7\u30b9\u30c6\u30a4\u30cb\u30eb-\u30b0\u30ea\u30b7\u30f3\uff08\u03b3-Glu-Cys-Gly\uff09\u3001CAS 70-18-8\u3001\u5206\u5b50\u5f0f C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, MW 307.32 g\/mol. GSH is the most abundant non-protein cellular thiol (millimolar intracellular concentrations) and the canonical reference compound for cellular antioxidant defence studies. The unique <strong>\u03b3-\u30da\u30d7\u30c1\u30c9\u7d50\u5408<\/strong> between glutamate&#8217;s \u03b3-carboxyl and cysteine&#8217;s amino group (rather than the standard \u03b1-peptide bond) makes GSH resistant to common peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT) can cleave it. Cells use GSH as the primary electron donor for glutathione peroxidase-mediated hydrogen-peroxide reduction, as the conjugating co-substrate for glutathione-S-transferase-mediated xenobiotic detoxification, and as the redox-status buffer that controls protein thiol-disulfide equilibrium. Supplied here as lyophilized USP-grade powder for clinical studies use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5408\u7269\u30af\u30e9\u30b9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-Glutamyl tripeptide; primary cellular non-protein thiol antioxidant; small-molecule peptide (\u03b3-linked, peptidase-resistant)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5316\u5b66\u540d<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">L-\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u3001\u9084\u5143\u578b\uff08\u03b3-L-\u30b0\u30eb\u30bf\u30df\u30eb-L-\u30b7\u30b9\u30c6\u30a4\u30cb\u30eb-\u30b0\u30ea\u30b7\u30f3; \u5225\u540d: GSH\u3001\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u904a\u96e2\u9178\u3001\u9084\u5143\u578b\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">70-18-8\uff08\u9084\u5143\u578bGSH\uff09; \u95a2\u9023\u7269\u8cea: 27025-41-8\uff08\u9178\u5316\u578bGSSG\u4e8c\u91cf\u4f53\u3001\u3053\u3061\u3089\u3067\u306f\u4f9b\u7d66\u3055\u308c\u307e\u305b\u3093\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">307.32 g\/mol\uff08\u904a\u96e2\u9178\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-L-\u30b0\u30eb\u30bf\u30df\u30eb-L-\u30b7\u30b9\u30c6\u30a4\u30cb\u30eb-\u30b0\u30ea\u30b7\u30f3\uff08\u03b3-Glu-Cys-Gly\uff09\u3002\u305d\u306e <strong>\u03b3-\u30da\u30d7\u30c1\u30c9\u7d50\u5408<\/strong> \u30b0\u30eb\u30bf\u30df\u30f3\u9178\u306e\u03b3-COOH\u5074\u9396\u3068\u30b7\u30b9\u30c6\u30a4\u30f3\u306e\u03b1-\u30a2\u30df\u30ce\u57fa\u306e\u9593\u3067\u3001\u6a19\u6e96\u7684\u306a\u03b1-\u30da\u30d7\u30c1\u30c9\u7d50\u5408\u3067\u306f\u306a\u304f\u3002\u3053\u306e\u975e\u6a19\u6e96\u7684\u306a\u7d50\u5408\u304c\u3001GSH\u3092\u4e00\u822c\u7684\u306a\u03b1-\u30da\u30d7\u30c1\u30c0\u30fc\u30bc\u306b\u5bfe\u3057\u3066\u8010\u6027\u306b\u3057\u3066\u3044\u308b\u7406\u7531\u3067\u3059 \u2014 \u03b3-\u30b0\u30eb\u30bf\u30df\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08\u03b3-GT\uff09\u306e\u307f\u304c\u3053\u308c\u3092\u5207\u65ad\u3057\u3001\u3053\u308c\u304c\u7d30\u80de\u5916\u3067\u306eGSH\u5206\u89e3\u3068\u518d\u5229\u7528\u306e\u5f8b\u901f\u6bb5\u968e\u3068\u306a\u308a\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>\u7d30\u80de\u306b\u304a\u3051\u308b3\u3064\u306e\u4e3b\u8981\u306a\u5f79\u5272<\/strong>. (1) <em>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\u3078\u306e\u96fb\u5b50\u4f9b\u4e0e\u4f53<\/em> (GPx\u30d5\u30a1\u30df\u30ea\u30fc) \u2014 2 GSH + H<sub>2<\/sub>O<sub>2<\/sub> \u2192 GSSG + 2 H<sub>2<\/sub>O, \u6a19\u6e96\u7684\u306a\u7d30\u80de\u5185\u904e\u9178\u5316\u6c34\u7d20\u9084\u5143\u53cd\u5fdc; \u305d\u306e\u5f8cGSSG\u306fNADPH\u4f9d\u5b58\u6027\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u9084\u5143\u9175\u7d20\u306b\u3088\u308a2\u3064\u306eGSH\u306b\u9084\u5143\u3055\u308c\u307e\u3059\u3002(2) <em>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3-S-\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\u306e\u88dc\u52a9\u57fa\u8cea<\/em> (GST\u30d5\u30a1\u30df\u30ea\u30fc) \u2014 \u89aa\u96fb\u5b50\u6027\u306e\u7570\u7269\u304a\u3088\u3073\u5185\u5728\u6027\u57fa\u8cea\u306bGSH\u3092\u62b1\u5408\u3057\u3001\u6392\u6cc4\u53ef\u80fd\u306a\u30e1\u30eb\u30ab\u30d7\u30c4\u30fc\u30eb\u9178\u62b1\u5408\u4f53\u3092\u751f\u6210\u3057\u307e\u3059\uff08\u809d\u81d3\u306e\u4e3b\u8981\u306a\u89e3\u6bd2\u7d4c\u8def\uff09\u3002(3) <em>\u9178\u5316\u9084\u5143\u72b6\u614b\u306e\u7de9\u885d\u5264<\/em> \u2014 GSH:GSSG\u6bd4\uff08\u6b63\u5e38\u7d30\u80de\u3067\u306f\u901a\u5e38\u7d04100:1\uff09\u306f\u3001\u30c1\u30aa\u30ec\u30c9\u30ad\u30b7\u30f3\u304a\u3088\u3073\u30b0\u30eb\u30bf\u30ec\u30c9\u30ad\u30b7\u30f3\u3092\u4ecb\u3057\u305f\u4ea4\u63db\u306b\u3088\u308a\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u30c1\u30aa\u30fc\u30eb-\u30b8\u30b9\u30eb\u30d5\u30a3\u30c9\u5e73\u8861\u3092\u5236\u5fa1\u3057\u3001\u6570\u5343\u3082\u306e\u9178\u5316\u9084\u5143\u611f\u53d7\u6027\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u6d3b\u6027\u3092\u8abf\u7bc0\u3057\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white crystalline powder; single-use vials. <strong>\u975e\u5e38\u306b\u5438\u6e7f\u6027\u304c\u9ad8\u3044<\/strong> \u2014 \u6c34\u5206\u5438\u53ce\u3092\u907f\u3051\u308b\u305f\u3081\u3001\u5404\u629c\u304d\u53d6\u308a\u5f8c\u306f\u901f\u3084\u304b\u306b\u30d0\u30a4\u30a2\u30eb\u3092\u518d\u5c01\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09\uff1b\u6ef4\u5b9a\u306b\u3088\u308a\u226598%\u304c\u9084\u5143\u578bGSH\u3067\u3042\u308b\u3053\u3068\u3092\u78ba\u8a8d\uff08\u9178\u5316\u578bGSSG\u542b\u91cf\u22642%\uff09\u3002USP\u30b0\u30ec\u30fc\u30c9\u53c2\u7167\u54c1\u3002<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u6c34 20 mg\/mL\uff1bPBS\uff08pH 7.2\uff09 10 mg\/mL \u2014 \u63d0\u4f9b\u3055\u308c\u305f\u30d0\u30a4\u30a2\u30eb\u6fc3\u5ea6\u3067\u306f\u5bb9\u6613\u306b\u6eb6\u89e3\u3057\u307e\u3059\u3002\u30c1\u30aa\u30fc\u30eb\uff08-SH\uff09\u57fa\u306e\u305f\u3081\u3001GSH\u306f\u7a7a\u6c17\u9178\u5316\u306b\u611f\u53d7\u6027\u304c\u3042\u308a\u307e\u3059 \u2014 \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u304b\u3089\u7528\u6642\u306b\u8abf\u88fd\u3057\u3001\u53ef\u80fd\u3067\u3042\u308c\u307024\u6642\u9593\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002DMSO\u306f\u7d30\u80de\u57f9\u990a\u30b9\u30c8\u30c3\u30af\u8abf\u88fd\u306e\u9069\u5207\u306a\u5171\u6eb6\u5a92\u3067\u3042\u308a\uff08\u6700\u5927100 mg\/mL\uff09\u3001\u7a7a\u6c17\u9178\u5316\u306b\u5bfe\u3059\u308b\u8ffd\u52a0\u306e\u4fdd\u8b77\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u77ed\u671f\u4f5c\u696d\u7528\u30b9\u30c8\u30c3\u30af\u306f\u5143\u306e\u5bc6\u5c01\u5305\u88c5\u30672\uff5e8\u2103\uff1b\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306f\u221220\u2103\uff08\u221220\u2103\u3067\u226536\u304b\u6708\u30012\uff5e8\u2103\u3067\u226518\u304b\u6708\u5b89\u5b9a\uff09\u3002\u518d\u69cb\u6210\u6c34\u6eb6\u6db2\uff1a2\uff5e8\u2103\u3001\u7d047\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\uff08\u7a7a\u6c17\u9178\u5316\u306b\u3088\u308bGSSG\u3078\u306e\u5909\u5316\u304c\u5236\u9650\u56e0\u5b50\u3067\u3059\uff09\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306e\u7e70\u308a\u8fd4\u3057\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/strong> \u2014\u7d2f\u7a4d\u30b5\u30a4\u30af\u30eb\u306fGSH\u2192GSSG\u306e\u9178\u5316\u3092\u52a0\u901f\u3057\u307e\u3059\u3002<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>L-\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08\u9084\u5143\u578b \/ GSH\uff09\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>L-\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08\u9084\u5143\u578b\u3001GSH\uff09<\/strong> \u306f\u3001\u771f\u6838\u751f\u7269\u306b\u304a\u3044\u3066\u6700\u3082\u8c4a\u5bcc\u306a\u975e\u30bf\u30f3\u30d1\u30af\u8cea\u6027\u7d30\u80de\u30c1\u30aa\u30fc\u30eb\u3067\u3042\u308a\u3001\u30df\u30ea\u30e2\u30eb\u6fc3\u5ea6\uff08\u307b\u3068\u3093\u3069\u306e\u7d30\u80de\u7a2e\u30671\uff5e10 mM\u3001\u809d\u7d30\u80de\u3067\u306f\u6700\u592710 mM\uff09\u3067\u7d30\u80de\u5185\u306b\u5b58\u5728\u3057\u3001\u7d30\u80de\u306e\u9178\u5316\u9084\u5143\u72b6\u614b\u306e\u30de\u30b9\u30bf\u30fc\u30d0\u30c3\u30d5\u30a1\u30fc\u3068\u3057\u3066\u6a5f\u80fd\u3057\u307e\u3059\u3002\u69cb\u9020\u7684\u306b\u306f\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u3001\u30b7\u30b9\u30c6\u30a4\u30f3\u3001\u30b0\u30ea\u30b7\u30f3\u304b\u3089\u306a\u308b\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\uff08\u03b3-Glu-Cys-Gly\uff09\u3067\u3001CAS\u756a\u53f7 70-18-8\u3001\u5206\u5b50\u5f0fC<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, molecular weight 307.32 g\/mol. The defining structural feature of glutathione is its <strong>\u03b3-\u30da\u30d7\u30c1\u30c9\u7d50\u5408<\/strong>. \u3002\u6a19\u6e96\u7684\u306a\u30da\u30d7\u30c1\u30c9\u306f\u3001\u3042\u308b\u30a2\u30df\u30ce\u9178\u306e\u03b1-\u30ab\u30eb\u30dc\u30ad\u30b7\u30eb\u57fa\u3068\u6b21\u306e\u30a2\u30df\u30ce\u9178\u306e\u03b1-\u30a2\u30df\u30ce\u57fa\u3068\u306e\u9593\u306e\u03b1-\u30da\u30d7\u30c1\u30c9\u7d50\u5408\u306b\u3088\u3063\u3066\u9023\u7d50\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u3067\u306f\u3001\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u3068\u30b7\u30b9\u30c6\u30a4\u30f3\u306e\u9593\u306e\u7d50\u5408\u306f\u975e\u5b9a\u578b\u3067\u3042\u308a\u3001\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u306e <em>\u03b3-\u30ab\u30eb\u30dc\u30ad\u30b7\u30eb\u57fa<\/em> of glutamate&#8217;s side chain and the \u03b1-amino of cysteine. This non-standard linkage is the molecular basis for glutathione&#8217;s resistance to common cellular peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT, GGT, EC 2.3.2.2) recognises and cleaves the \u03b3-bond. As a result, glutathione is uniquely stable in the cellular cytosol where it would otherwise be rapidly degraded by \u03b1-peptidase activity, and \u03b3-GT-mediated extracellular degradation is the rate-limiting step of glutathione recycling. Glutathione is synthesised in two ATP-dependent steps by the cytosolic enzymes <strong>\u30b0\u30eb\u30bf\u30df\u30f3\u9178-\u30b7\u30b9\u30c6\u30a4\u30f3\u30ea\u30ac\u30fc\u30bc\uff08GCL\uff09<\/strong> \u2014\u3053\u306e\u9175\u7d20\u306f\u03b3-\u30b0\u30eb\u30bf\u30df\u30eb-\u30b7\u30b9\u30c6\u30a4\u30f3\u7d50\u5408\u3092\u5f62\u6210\u3057\u307e\u3059\u2014\u3001\u305d\u3057\u3066 <strong>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u5408\u6210\u9175\u7d20\uff08GSS\uff09<\/strong> \u2014 which adds the C-terminal glycine. GCL is the rate-limiting enzyme and is feedback-inhibited by glutathione itself, providing autoregulation of cellular glutathione levels. Cysteine availability is the other major rate-limiting input \u2014 which is why N-acetylcysteine (NAC), a cysteine prodrug, is the canonical clinical intervention for boosting cellular glutathione synthesis in oxidative-stress and detoxification contexts (the basis of NAC&#8217;s approval for paracetamol overdose and other clinical indications). Glutathione exists in cells in two interconverting forms: the <strong>\u9084\u5143\u578b\uff08GSH\uff09<\/strong> \u904a\u96e2\u30c1\u30aa\u30fc\u30eb\uff08-SH\uff09\u57fa\u3092\u6301\u3061\u3001 <strong>\u9178\u5316\u578b\uff08GSSG\uff09<\/strong> 2\u3064\u306eGSH\u5206\u5b50\u304c\u30b8\u30b9\u30eb\u30d5\u30a3\u30c9\u7d50\u5408\u3067\u9023\u7d50\u3055\u308c\u305f\u3082\u306e\u3067\u3059\u3002 GSH:GSSG\u6bd4\uff08\u5065\u5eb7\u306a\u7d30\u80de\u3067\u306f\u901a\u5e38\u7d04100\uff1a1\u3001\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u4e0b\u3067\u306f10\uff1a1\u4ee5\u4e0b\u306b\u4f4e\u4e0b\uff09\u306f\u3001\u6a19\u6e96\u7684\u306a\u7d30\u80de\u9178\u5316\u9084\u5143\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u3067\u3059\u3002 GSSG\u306f\u3001\u4ee5\u4e0b\u306e\u9175\u7d20\u306b\u3088\u3063\u30662\u5206\u5b50\u306eGSH\u306b\u9084\u5143\u3055\u308c\u307e\u3059\uff1a <strong>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u30ec\u30c0\u30af\u30bf\u30fc\u30bc\uff08GR\u3001GSR\uff09<\/strong>, an NADPH-dependent flavoenzyme \u2014 connecting the GSH redox system to NADPH availability and ultimately to the pentose phosphate pathway. This is why pentose-phosphate-pathway disruption (G6PD deficiency, glucose-6-phosphate availability) impairs GSH-system function and triggers oxidative cell damage. The pharmaceutical-grade material supplied here is the reduced GSH form, supplied as lyophilized powder for reconstitution and protocol use alongside the peptide catalogue. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 3\u3064\u306e\u4e3b\u8981\u306a\u7d30\u80de\u5185\u5f79\u5272<\/h2>\n<p>GSH\u306e\u751f\u7269\u5b66\u7684\u30e1\u30ab\u30cb\u30ba\u30e0\u306f\u3001\u516c\u8868\u3055\u308c\u305f\u751f\u5316\u5b66\u7814\u7a76\u3067\u5341\u5206\u306b\u7279\u6027\u304c\u660e\u3089\u304b\u306b\u3055\u308c\u3066\u3044\u308b3\u3064\u306e\u4e3b\u8981\u306a\u7d30\u80de\u5185\u5f79\u5272\u306e\u7dcf\u4f53\u3067\u3059\uff1a<\/p>\n<ul>\n<li><strong>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u30da\u30eb\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\uff08GPx\uff09\u306e\u57fa\u8cea \u2014 \u904e\u9178\u5316\u6c34\u7d20\u304a\u3088\u3073\u8102\u8cea\u904e\u9178\u5316\u7269\u306e\u9084\u5143<\/strong> \u2014 GSH\u306e\u6700\u3082\u5f15\u7528\u3055\u308c\u308b\u5f79\u5272\u3067\u3059\u3002GPx\u30d5\u30a1\u30df\u30ea\u30fc\uff08GPx1\uff5e8\u3001\u30bb\u30ec\u30f3\u4f9d\u5b58\u6027GPx1\u304c\u6700\u3082\u8c4a\u5bcc\uff09\u306f\u4ee5\u4e0b\u306e\u53cd\u5fdc\u3092\u89e6\u5a92\u3057\u307e\u3059 <em>2 GSH + ROOH \u2192 GSSG + ROH + H<sub>2<\/sub>O<\/em>, \u3001\u904e\u9178\u5316\u6c34\u7d20\u3068\u8102\u8cea\u30d2\u30c9\u30ed\u30da\u30eb\u30aa\u30ad\u30b7\u30c9\u3092\u305d\u308c\u305e\u308c\u6c34\u3068\u30a2\u30eb\u30b3\u30fc\u30eb\u306b\u9084\u5143\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u547c\u5438\u3001NADPH\u30aa\u30ad\u30b7\u30c0\u30fc\u30bc\u6d3b\u6027\u3001\u305d\u306e\u4ed6\u306e\u9178\u5316\u30d7\u30ed\u30bb\u30b9\u306b\u3088\u3063\u3066\u751f\u6210\u3055\u308c\u308b\u6d3b\u6027\u9178\u7d20\u7a2e\u306b\u5bfe\u3059\u308b\u7d30\u80de\u306e\u4e3b\u8981\u306a\u9632\u5fa1\u6a5f\u69cb\u3067\u3059\u3002GPx4\u306f\u8102\u8cea\u30d2\u30c9\u30ed\u30da\u30eb\u30aa\u30ad\u30b7\u30c9\u306e\u9084\u5143\u3092\u89e6\u5a92\u3059\u308b\u7279\u5b9a\u306e\u30a2\u30a4\u30bd\u30d5\u30a9\u30fc\u30e0\u3067\u3042\u308a\u3001\u305d\u306e\u6a5f\u80fd\u55aa\u5931\u304c\u5f15\u304d\u91d1\u3068\u306a\u308b\u5206\u5b50\u6a19\u7684\u3067\u3059 <strong>\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9<\/strong> \u2014 the iron-dependent regulated cell death pathway that has become a major focus of recent cancer-studies and neurodegenerative-disease studies.<\/li>\n<li><strong>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3-S-\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08GST\uff09\u306e\u5171\u57fa\u8cea \u2014 \u751f\u4f53\u7570\u7269\u304a\u3088\u3073\u5185\u5728\u6027\u7269\u8cea\u306e\u62b1\u5408<\/strong> \u2014 GST\u30d5\u30a1\u30df\u30ea\u30fc\uff08\u7d30\u80de\u8cea\u3001\u30df\u30af\u30ed\u30bd\u30fc\u30e0\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u30e1\u30f3\u30d0\u30fc\uff1b\u7d0420\u306e\u30d2\u30c8GST\u30a2\u30a4\u30bd\u30d5\u30a9\u30fc\u30e0\uff09\u306f\u3001GSH\u30c1\u30aa\u30fc\u30eb\u57fa\u3092\u4ecb\u3057\u305fGSH\u306e\u6c42\u96fb\u5b50\u6027\u57fa\u8cea\u3078\u306e\u62b1\u5408\u3092\u89e6\u5a92\u3057\u3001GSH-S-\u62b1\u5408\u4f53\u4ed8\u52a0\u7269\u3092\u751f\u6210\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u305d\u306e\u5f8c\u3001\u03b3-GT\u304a\u3088\u3073\u30b8\u30da\u30d7\u30c1\u30c0\u30fc\u30bc\u306b\u3088\u3063\u3066\u30e1\u30eb\u30ab\u30d7\u30c4\u30fc\u30eb\u9178\u3078\u3068\u51e6\u7406\u3055\u308c\u3001\u6392\u6cc4\u3055\u308c\u307e\u3059\u3002\u3053\u308c\u306f\u809d\u81d3\u304a\u3088\u3073\u305d\u306e\u4ed6\u306e\u7d44\u7e54\u306b\u304a\u3051\u308b\u4e2d\u5fc3\u7684\u306a\u7b2cII\u76f8\u89e3\u6bd2\u7d4c\u8def\u3067\u3042\u308a\u3001\u5e83\u7bc4\u306a\u751f\u4f53\u7570\u7269\uff08\u85ac\u7269\u4ee3\u8b1d\u7269\u3001\u74b0\u5883\u5316\u5b66\u7269\u8cea\u3001\u7b2cI\u76f8\u30b7\u30c8\u30af\u30ed\u30e0P450\u4ee3\u8b1d\u7523\u7269\uff09\u3001\u5185\u5728\u6027\u6c42\u96fb\u5b50\u7269\u8cea\uff084-\u30d2\u30c9\u30ed\u30ad\u30b7\u30ce\u30cd\u30ca\u30fc\u30eb\u3001\u8102\u8cea\u904e\u9178\u5316\u306b\u3088\u308b\u30a2\u30af\u30ed\u30ec\u30a4\u30f3\uff09\u3001\u304a\u3088\u3073\u53cd\u5fdc\u6027\u4e2d\u9593\u4f53\uff08\u30d1\u30e9\u30bb\u30bf\u30e2\u30fc\u30eb\u306b\u3088\u308bNAPQI\u3001\u30d1\u30e9\u30bb\u30bf\u30e2\u30fc\u30eb\u904e\u5270\u6442\u53d6\u6642\u306eNAC\u7642\u6cd5\u306e\u57fa\u76e4\uff09\u3092\u51e6\u7406\u3057\u307e\u3059\u3002<\/li>\n<li><strong>\u9178\u5316\u9084\u5143\u72b6\u614b\u306e\u7de9\u885d\u5264 \u2014 \u30bf\u30f3\u30d1\u30af\u8cea\u30c1\u30aa\u30fc\u30eb-\u30b8\u30b9\u30eb\u30d5\u30a3\u30c9\u5e73\u8861\u306e\u8abf\u7bc0<\/strong> \u2014 The cellular GSH:GSSG ratio sets the thermodynamic equilibrium for protein-thiol redox state via thioredoxin- and glutaredoxin-mediated exchange. Thousands of cellular proteins have redox-sensitive cysteine residues whose thiol-disulfide state is regulated by this equilibrium \u2014 including key transcription factors (NF-\u03baB, AP-1, Nrf2, p53), signalling kinases (PTPs, PTEN), apoptosis machinery (caspases), and metabolic enzymes (glyceraldehyde-3-phosphate dehydrogenase, others). GSH-mediated redox buffering is therefore not just an antioxidant defence but a signalling regulatory mechanism \u2014 a fact that has emerged in published studies over the past two decades and is one of the most-cited rationales for the use of GSH in protocols beyond simple antioxidant supplementation.<\/li>\n<li><strong>\u30b7\u30b9\u30c6\u30a4\u30f3\u8caf\u8535\u5eab\u304a\u3088\u3073\u81d3\u5668\u9593\u30a2\u30df\u30ce\u9178\u8f38\u9001<\/strong> \u2014 GSH\u306f\u3001\u7d44\u7e54\u5185\u3067\u5b89\u5b9a\u3057\u8f38\u9001\u53ef\u80fd\u306a\u30b7\u30b9\u30c6\u30a4\u30f3\u306e\u8caf\u8535\u5eab\u3068\u3057\u3066\u6a5f\u80fd\u3057\u307e\u3059\u3002\u30b7\u30b9\u30c6\u30a4\u30f3\u306f\u65b0\u3057\u3044\u30bf\u30f3\u30d1\u30af\u8cea\u5408\u6210\u304a\u3088\u3073\u3055\u3089\u306a\u308bGSH\u5408\u6210\u306e\u5f8b\u901f\u30a2\u30df\u30ce\u9178\u3067\u3059\u3002\u904a\u96e2\u578b\u306e\u30b7\u30b9\u30c6\u30a4\u30f3\u306f\u4ee3\u8b1d\u7684\u306b\u4e0d\u5b89\u5b9a\u3067\u3042\u308a\uff08\u30b7\u30b9\u30c1\u30f3\u3078\u306e\u81ea\u52d5\u9178\u5316\u3001H<sub>2<\/sub>S\u306e\u751f\u6210\u306a\u3069\uff09\u3001\u305d\u306e\u305f\u3081\u4f53\u5185\u306f\u4e3b\u306bGSH\u3068\u3057\u3066\u30b7\u30b9\u30c6\u30a4\u30f3\u30d7\u30fc\u30eb\u3092\u7dad\u6301\u3057\u3001\u81d3\u5668\u9593\uff08\u7279\u306b\u809d\u81d3\u2192\u814e\u81d3\u3001\u809d\u81d3\u2192\u4ed6\u306e\u7d44\u7e54\uff09\u3067GSH\u3068\u3057\u3066\u30b7\u30b9\u30c6\u30a4\u30f3\u3092\u8f38\u9001\u3057\u3001\u6a19\u7684\u7d44\u7e54\u3067\u03b3-GT\u306b\u3088\u3063\u3066\u30b7\u30b9\u30c6\u30a4\u30f3\u306b\u623b\u3055\u308c\u307e\u3059\u3002<\/li>\n<li><strong>\u76f4\u63a5\u7684\u306a\u30e9\u30b8\u30ab\u30eb\u6d88\u53bb<\/strong> \u2014 \u9175\u7d20\u7684\u306a\u5f79\u5272\u306b\u52a0\u3048\u3001GSH\u306f\u30c1\u30aa\u30fc\u30eb\u57fa\u3092\u4ecb\u3057\u3066\u30d2\u30c9\u30ed\u30ad\u30b7\u30eb\u30e9\u30b8\u30ab\u30eb\u3001\u30da\u30eb\u30aa\u30ad\u30b7\u30eb\u30e9\u30b8\u30ab\u30eb\u3001\u6d3b\u6027\u7a92\u7d20\u7a2e\u3068\u76f4\u63a5\u53cd\u5fdc\u3057\u307e\u3059\u3002\u91cf\u7684\u306b\u306f\u3001\u3053\u306e\u7d4c\u8def\u306f\u9175\u7d20\u7684\u306aGPx\u4ecb\u5728\u30e1\u30ab\u30cb\u30ba\u30e0\u3088\u308a\u3082\u7dcf\u6297\u9178\u5316\u9632\u5fa1\u3078\u306e\u5bc4\u4e0e\u306f\u5c0f\u3055\u3044\u3082\u306e\u306e\u3001\u9175\u7d20\u7cfb\u304c\u98fd\u548c\u72b6\u614b\u306b\u3042\u308b\u304b\u5b58\u5728\u3057\u306a\u3044\u533a\u753b\u3084\u6761\u4ef6\u4e0b\uff08\u80ba\u80de\u88ab\u8986\u6db2\u4e2d\u306e\u7d30\u80de\u5916GSH\u3001\u8178\u7ba1\u5185\u8154\u306eGSH\u306a\u3069\uff09\u3067\u306f\u91cd\u8981\u3067\u3059\u3002<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable GSH is well-characterised: IV administration produces rapid systemic distribution with peak plasma concentrations within minutes, but plasma half-life is short (~10\u201315 minutes) due to rapid \u03b3-GT-mediated breakdown to cysteinylglycine and subsequent re-synthesis or further breakdown at target tissues. The brief plasma residence is one of the reasons why daily or twice-daily IV dosing protocols are common in published GSH studies. Cell-membrane permeability of intact GSH is low \u2014 cells primarily import the constituent amino acids and re-synthesise GSH intracellularly. This is why oral GSH is poorly bioavailable and why injectable preparations (or alternatively NAC as a cysteine prodrug) are required for effective tissue delivery in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GSH is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>\u7d30\u80de\u306e\u6297\u9178\u5316\u9632\u5fa1 \u2014 \u6a19\u6e96\u7684\u306a\u53c2\u7167\u5316\u5408\u7269<\/strong> \u2014 by far the most-cited cellular antioxidant in the published literature; standard reference compound for any new antioxidant intervention studies; the molecular gold standard for cellular redox-status analysis<\/li>\n<li><strong>Hydrogen peroxide and lipid peroxide reduction studies<\/strong> \u2014 direct GPx substrate; used in published studies on GPx isoform pharmacology, peroxide-handling pathway dissection, and the integration of GSH with thioredoxin and peroxiredoxin redox systems<\/li>\n<li><strong>Ferroptosis studies<\/strong> \u2014 GPx4-mediated lipid-hydroperoxide reduction is the gatekeeper of ferroptosis; GSH and its synthesis-pathway interventions (BSO, erastin, RSL3) are the canonical tools for ferroptosis induction \/ suppression studies in cancer, neurodegeneration, and ischaemia-reperfusion contexts<\/li>\n<li><strong>Phase II detoxification and xenobiotic-conjugation studies<\/strong> \u2014 GST substrate for the central liver-detoxification pathway; used in studies on drug-metabolite handling, environmental-chemical exposure, paracetamol-induced hepatotoxicity (NAPQI scavenging), and the broader pharmacology of mercapturic-acid conjugation<\/li>\n<li><strong>Protein-thiol redox signalling studies<\/strong> \u2014 the GSH:GSSG ratio controls thiol-disulfide equilibrium of thousands of cellular proteins; used in studies on redox-sensitive transcription factors (Nrf2, NF-\u03baB, AP-1), kinase regulation (PTPs, PTEN), and the broader cellular &#8220;redoxome&#8221;<\/li>\n<li><strong>Mitochondrial dysfunction and ageing studies<\/strong> \u2014 mitochondrial GSH levels decline with age and in many disease models; published studies uses exogenous GSH and GSH-pathway interventions to probe mitochondrial-redox contributions to ageing, neurodegeneration, and metabolic disease<\/li>\n<li><strong>Hepatology and liver-injury studies<\/strong> \u2014 GSH is most abundant in hepatocytes (5\u201310 mM concentration); used in published studies on alcoholic liver disease, NAFLD\/MASH, viral hepatitis models, and paracetamol-overdose \/ drug-induced liver injury<\/li>\n<li><strong>Hematology and erythrocyte studies<\/strong> \u2014 erythrocyte GSH is the major defence against oxidative haemolysis; used in studies on G6PD deficiency, sickle-cell disease, oxidative haemolysis pharmacology<\/li>\n<li><strong>Cancer redox and chemoprotection studies<\/strong> \u2014 many chemotherapeutic drugs generate ROS as part of their mechanism, and tumour cells often have elevated GSH levels; published studies uses GSH and GSH-pathway interventions to dissect chemotherapy redox biology<\/li>\n<\/ul>\n<p>For broader context on cellular cofactor and redox \/ antioxidant compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/ja\/b12-cyanocobalamin\/\">B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09<\/a> (small-molecule companion cofactor \u2014 methylation cycle), <a href=\"https:\/\/medsbase.com\/ja\/l-carnitine\/\">L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/a> \uff08\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u8102\u80aa\u9178\u30b7\u30e3\u30c8\u30eb \u2014 \u88dc\u52a9\u4f4e\u5206\u5b50\uff09, <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a> \uff08\u76f4\u63a5\u7684\u306a\u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u30d7\u30fc\u30eb\u88dc\u5145 \u2014 \u9178\u5316\u9084\u5143\u96fb\u5b50\u4f1d\u9054\uff09, <a href=\"https:\/\/medsbase.com\/ja\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (NNMT\u963b\u5bb3\u306b\u3088\u308bNAD\u8ef8\u6e29\u5b58)\u3001\u304a\u3088\u3073 <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> (\u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u7d50\u5408\u6027\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u6297\u9178\u5316\u30da\u30d7\u30c1\u30c9)\u3002\u3059\u3079\u3066\u306e <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">peptides &amp; compounds catalog<\/a>, \u3001\u307e\u305f\u306f\u53b3\u9078\u3055\u308c\u305f <a href=\"https:\/\/medsbase.com\/ja\/best-longevity-peptides\/\">longevity compounds<\/a> \u30cf\u30d6\u3002 <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase stocks Glutathione in three lyophilized vial sizes calibrated to typical protocol dose ranges. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>600 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 entry-level protocols, in-vitro antioxidant-defence panels, dose-titration work, single-cohort murine titration; convenient for reconstitution at 100\u2013200 mg\/mL working stocks<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>900 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mid-strength \u2014 extended in-vivo rodent dosing protocols, IV-protocols, multi-cohort sample sizes, hepatology \/ oxidative-stress model studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1500 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">High-strength vial \u2014 clinical-translational dose-range protocols (Italian Tationil IV dosing is 600\u20132400 mg\/d for hepatology studies), large-cohort metabolic studies, multi-arm comparator work; lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical entity (lyophilized L-glutathione reduced form, \u226599% HPLC purity, USP-grade titration-confirmed reduced-form content). The 1500 mg vial provides the lowest per-mg cost for clinical-translational protocols. Users should determine specific dose ranges from peer-reviewed literature appropriate to the protocol. <\/p>\n<h2>\u6bd4\u8f03 \u2014 \u30b0\u30eb\u30bf\u30c1\u30aa\u30f3 vs NAD\u207a<\/h2>\n<p>\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u3068 <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a> \u306f\u3001\u3053\u306e\u30ab\u30bf\u30ed\u30b0\u3067\u6700\u3082\u7814\u7a76\u3055\u308c\u3066\u3044\u308b\u4f4e\u5206\u5b50\u7d30\u80de\u30ec\u30c9\u30c3\u30af\u30b9\uff0f\u88dc\u9175\u7d20\u5316\u5408\u7269\u306e2\u3064\u3067\u3042\u308a\u3001\u305d\u308c\u3089\u306f\u3001\u7d30\u80de\u30ec\u30c9\u30c3\u30af\u30b9\u751f\u7269\u5b66\u306e\u95a2\u9023\u306f\u3042\u308b\u304c\u6a5f\u69cb\u7684\u306b\u7570\u306a\u308b\u5206\u5c90\u306b\u4f4d\u7f6e\u3057\u3066\u3044\u307e\u3059\u3002GSH\u306f\u4e3b\u8981\u306a <em>\u7d30\u80de\u6297\u9178\u5316\u9632\u5fa1<\/em> \u4f4e\u5206\u5b50 \u2014 \u30df\u30ea\u30e2\u30eb\u6fc3\u5ea6\u3067\u5b58\u5728\u3057\u3001GPx\u57fa\u8cea\u6a5f\u69cb\u3092\u4ecb\u3057\u3066\u904e\u9178\u5316\u7269\u3092\u9084\u5143\u3057\u307e\u3059\u3002NAD\u207a\u306f\u4e3b\u8981\u306a <em>\u7d30\u80de\u96fb\u5b50\u4f1d\u9054<\/em> coenzyme \u2014 reducible to NADH for electron transport in glycolysis \/ TCA cycle \/ \u03b2-oxidation, and substrate for sirtuins and PARPs. The two systems are interconnected: NADPH (made from NAD via the pentose phosphate pathway) is the reducing equivalent that regenerates GSH from GSSG via glutathione reductase. Studies that probes cellular redox biology often manipulates both pools and compares the consequences. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08GSH\uff09<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD\u207a<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5316\u5b66\u5206\u985e<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u03b3-\u30b0\u30eb\u30bf\u30df\u30eb\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\uff08\u03b3-Glu-Cys-Gly\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b8\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u88dc\u9175\u7d20\uff08\u30a2\u30c7\u30cb\u30f3\uff0b\u30cb\u30b3\u30c1\u30f3\u30a2\u30df\u30c9\uff0b\u30b8\u30db\u30b9\u30d5\u30a7\u30fc\u30c8\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">307.32 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">663.43 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u7d30\u80de\u306b\u304a\u3051\u308b\u5f79\u5272<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6297\u9178\u5316\u9632\u5fa1 \u2014 GPx\u57fa\u8cea\uff08\u904e\u9178\u5316\u7269\u9084\u5143\uff09\u3001GST\u5171\u57fa\u8cea\uff08\u751f\u4f53\u7570\u7269\u62b1\u5408\uff09\u3001\u9178\u5316\u9084\u5143\u72b6\u614b\u30d0\u30c3\u30d5\u30a1\u30fc<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u96fb\u5b50\u4f1d\u9054\u88dc\u9175\u7d20 \u2014 \u03b2\u9178\u5316\u3001\u89e3\u7cd6\u7cfb\u3001TCA\u56de\u8def\u306e\u57fa\u8cea\uff1b\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\u304a\u3088\u3073PARP\u306e\u57fa\u8cea<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u7d30\u80de\u5185\u6fc3\u5ea6<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\uff5e10 mM\uff08\u30df\u30ea\u30e2\u30eb \u2014 \u6700\u3082\u8c4a\u5bcc\u306a\u975e\u30bf\u30f3\u30d1\u30af\u8cea\u30c1\u30aa\u30fc\u30eb\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u7d040.3\uff5e1 mM\uff08NAD\u30d7\u30fc\u30eb\u3001\u30de\u30a4\u30af\u30ed\u30e2\u30eb\u304b\u3089\u9ad8\u00b5M\uff09<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6297\u9178\u5316\u9632\u5fa1\u3001\u30d5\u30a7\u30ed\u30c8\u30fc\u30b7\u30b9\u3001\u7b2cII\u76f8\u89e3\u6bd2\u3001\u9178\u5316\u9084\u5143\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u3001\u809d\u81d3\u5b66\u3001\u30d1\u30e9\u30bb\u30bf\u30e2\u30fc\u30eb\u8a98\u767a\u6027\u640d\u50b7<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30b5\u30fc\u30c1\u30e5\u30a4\u30f3\u751f\u7269\u5b66\u3001\u9577\u5bff\u3001\u7d30\u80de\u8001\u5316\u3001NAD\u8ef8\u306e\u9178\u5316\u9084\u5143\u8abf\u7bc0<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u8840\u6f3f\u4e2d\u5b89\u5b9a\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u77ed\u3044 \u2014 \u7d0410\uff5e15\u5206\u306e\u534a\u6e1b\u671f\uff08\u03b3-GT\u306b\u3088\u308b\u7d30\u80de\u5916\u5206\u89e3\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u975e\u5e38\u306b\u77ed\u6642\u9593 \u2014 \u6570\u5206\uff08\u6eb6\u6db2\u4e2d\u3067\u6025\u901f\u306b\u9178\u5316\u30fb\u5206\u89e3\u3055\u308c\u307e\u3059\uff09<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u95a2\u9023\u6027<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">NADPH\uff08NAD\u7531\u6765\uff09\u306f\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u30ec\u30c0\u30af\u30bf\u30fc\u30bc\u3092\u4ecb\u3057\u3066GSSG\u304b\u3089GSH\u3092\u518d\u751f\u3057\u307e\u3059<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">NADPH\u306e\u95a2\u9023\u6027\u306f\u3001NAD\u30d7\u30fc\u30eb\u3068GSH\u7cfb\u306e\u9084\u5143\u80fd\u529b\u3092\u7d50\u3073\u3064\u3051\u307e\u3059<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u81e8\u5e8a\u4f7f\u7528<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u30a4\u30bf\u30ea\u30a2\uff0f\u65e5\u672c\uff0f\u97d3\u56fd\u3067\u627f\u8a8d\u3055\u308c\u305f\u6ce8\u5c04\u5264\uff08Tationil\u306a\u3069\uff1b\u809d\u81d3\u75c5\u5b66\u3001\u9178\u5316\u30b9\u30c8\u30ec\u30b9\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Not approved as a clinical therapeutic; studies-only compound<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on cellular antioxidant defence, ferroptosis, Phase II detoxification, or redox signalling, Glutathione is the canonical reference compound. For studies focused on sirtuin biology, longevity-axis biochemistry, or NAD-dependent redox regulation, <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a> is the more targeted tool. The two compounds are commonly co-administered in studies that probes the integrated cellular-redox-system response to oxidative stress, ageing, or mitochondrial dysfunction. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 BAC\u6c34\u304c\u5fc5\u8981\u3067\u3059\u304b\uff1f<\/strong> \u51cd\u7d50\u4e7e\u71e5\u54c1\u306e\u5fa9\u5143\u306b\u306f\u6ec5\u83cc\u9759\u83cc\u6c34\u304c\u5fc5\u8981\u3067\u3059\u3002\u672c\u88fd\u54c1\u3068\u4f75\u305b\u3066\u5f53\u793e\u306e <a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 30 mL\u30de\u30eb\u30c1\u30c9\u30fc\u30ba\u30d0\u30a4\u30a2\u30eb\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u3001USP\u30b0\u30ec\u30fc\u30c9\u3002<\/div>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u672a\u958b\u5c01\u306e\u307e\u307e2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u9577\u671f\u4fdd\u5b58\u306e\u5834\u5408\u306f\u3001\u672a\u958b\u5c01\u306e\u30d0\u30a4\u30a2\u30eb\u3092-20\u00b0C\u3067\u51cd\u7d50\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\uff08-20\u00b0C\u306736\u304b\u6708\u4ee5\u4e0a\u5b89\u5b9a\uff1b2\uff5e8\u00b0C\u306718\u304b\u6708\u4ee5\u4e0a\uff09\u3002\u51cd\u7d50\u4e7e\u71e5GSH\u306f <strong>\u975e\u5e38\u306b\u5438\u6e7f\u6027\u304c\u9ad8\u3044<\/strong> \u2014 \u5438\u6e7f\u3092\u907f\u3051\u308b\u305f\u3081\u3001\u5404\u56de\u306e\u629c\u304d\u53d6\u308a\u5f8c\u306f\u901f\u3084\u304b\u306b\u30d0\u30a4\u30a2\u30eb\u3092\u518d\u5c01\u3057\u3066\u304f\u3060\u3055\u3044\uff08GSH \u2192 GSSG\u3078\u306e\u9178\u5316\u3092\u4fc3\u9032\u3057\u307e\u3059\uff09\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u3001\u6ec5\u83cc\u6c34\u3001\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3001\u307e\u305f\u306fPBS\uff08pH 7.2\uff09\u3092\u6ce8\u5165\u3057\u307e\u3059\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u3002600 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u3001\u5e0c\u91c8\u6db26.0 mL\u3067100 mg\/mL\u306e\u4f5c\u696d\u539f\u6db2\u304c\u5f97\u3089\u308c\u307e\u3059\uff1b3.0 mL\u3067\u306f200 mg\/mL\u3067\u3059\u3002900 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u30019.0 mL\u3067100 mg\/mL\uff1b4.5 mL\u3067200 mg\/mL\u3067\u3059\u30021500 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u30017.5 mL\u3067200 mg\/mL\u539f\u6db2\uff1b15 mL\u3067100 mg\/mL\u3067\u3059\u3002GSH\u306f\u5ba4\u6e29\u3067\u7a4f\u3084\u304b\u306b\u65cb\u56de\u3055\u305b\u308b\u3068\u901f\u3084\u304b\u306b\u6eb6\u89e3\u3057\u307e\u3059\u3002 <strong>\u518d\u69cb\u6210GSH\u306b\u304a\u3044\u3066\u91cd\u8981\u306a\u70b9\uff1a<\/strong> \u30c1\u30aa\u30fc\u30eb\uff08-SH\uff09\u57fa\u306f <strong>\u7a7a\u6c17\u9178\u5316\u306b\u654f\u611f\u3067\u3059<\/strong> \u2014 \u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u51b7\u8535\u4e0b\u3067\u3082\u5f90\u3005\u306b\u9178\u5316\u578b\uff08GSSG\uff09\u3078\u3068\u9178\u5316\u3055\u308c\u307e\u3059\u3002\u53ef\u80fd\u306a\u9650\u308a\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u304b\u3089\u7528\u6642\u8abf\u88fd\u3057\u3001\u518d\u6eb6\u89e3\u5f8c\u306f\u51b7\u8535\u30677\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u3057\u305f\u6750\u6599\u3092\u9577\u671f\u4fdd\u5b58\u3059\u308b\u5834\u5408\u306f\u3001\u91d1\u5c5e\u89e6\u5a92\u306b\u3088\u308b\u9178\u5316\u3092\u9045\u5ef6\u3055\u305b\u308b\u305f\u3081\u306b\u30ad\u30ec\u30fc\u30c8\u5264\uff081 mM EDTA\uff09\u3092\u6dfb\u52a0\u3059\u308b\u304b\u3001\u4e0d\u6d3b\u6027\u96f0\u56f2\u6c17\u4e0b\uff08\u30a2\u30eb\u30b4\u30f3\u307e\u305f\u306f\u7a92\u7d20\u30d1\u30fc\u30b8\uff09\u3067\u4fdd\u5b58\u3059\u308b\u304b\u3001DMSO\u5171\u6eb6\u5a92\uff08\u8ffd\u52a0\u306e\u4fdd\u8b77\u52b9\u679c\u3042\u308a\uff09\u3092\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u878d\u89e3\u3092\u7e70\u308a\u8fd4\u3055\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u9855\u8457\u306a\u8272\u8abf\u5909\u5316\uff08\u9ec4\u8272\uff0f\u8910\u8272\uff09\u3084\u6c88\u6bbf\u304c\u8a8d\u3081\u3089\u308c\u305f\u5834\u5408\u306f\u5ec3\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2>\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>\u9084\u5143\u578b\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08GSH\uff09\u3068\u9178\u5316\u578b\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08GSSG\uff09\u306e\u9055\u3044\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p>GSH is the reduced form with a free thiol (-SH) group on its cysteine residue \u2014 the biologically active form that serves as the cellular antioxidant. GSSG is the oxidised dimer form where two GSH molecules are linked through their cysteine sulfurs by a disulfide bridge \u2014 the spent form that needs to be re-reduced to 2 GSH by glutathione reductase. The cellular GSH:GSSG ratio (typically ~100:1 in healthy cells, dropping to 10:1 or lower under oxidative stress) is the canonical biomarker of cellular redox status. We supply the reduced GSH form; users requiring GSSG specifically should consult dedicated suppliers. <\/p>\n<h3>GSH\u304c\u901a\u5e38\u306e\u03b1-\u30da\u30d7\u30c1\u30c9\u7d50\u5408\u3067\u306f\u306a\u304f\u03b3-\u30da\u30d7\u30c1\u30c9\u7d50\u5408\u3092\u6301\u3064\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u306e\u03b3-COOH\u3068\u30b7\u30b9\u30c6\u30a4\u30f3\u306e\u03b1-NH<sub>2<\/sub> \u3068\u306e\u9593\u306e\u975e\u6a19\u6e96\u7684\u306a\u03b3-\u30da\u30d7\u30c1\u30c9\u7d50\u5408\u3053\u305d\u304c\u3001\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u306b\u7d30\u80de\u5185\u30da\u30d7\u30c1\u30c0\u30fc\u30bc\u8010\u6027\u3092\u4ed8\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002\u6a19\u6e96\u7684\u306a\u7d30\u80de\u5185\u03b1-\u30da\u30d7\u30c1\u30c0\u30fc\u30bc\uff08\u30a2\u30df\u30ce\u30da\u30d7\u30c1\u30c0\u30fc\u30bc\u3001\u30ab\u30eb\u30dc\u30ad\u30b7\u30da\u30d7\u30c1\u30c0\u30fc\u30bc\uff09\u306f\u03b1-\u30da\u30d7\u30c1\u30c9\u7d50\u5408\u306e\u307f\u3092\u8a8d\u8b58\u3057\u3001\u03b3-\u7d50\u5408\u3092\u5207\u65ad\u3067\u304d\u307e\u305b\u3093\u3002\u03b3-\u30b0\u30eb\u30bf\u30df\u30eb\u30c8\u30e9\u30f3\u30b9\u30d5\u30a7\u30e9\u30fc\u30bc\uff08\u03b3-GT\u3001GGT\uff09\u306e\u307f\u304c\u03b3-\u7d50\u5408\u3092\u8a8d\u8b58\u30fb\u5207\u65ad\u3057\u307e\u3059\u3002\u305d\u3057\u3066\u03b3-GT\u306fGSH\u5206\u89e3\u306e\u5f8b\u901f\u9175\u7d20\u3067\u3042\u308a\u3001\u4e3b\u306b\u4e0a\u76ae\u7d30\u80de\uff08\u814e\u81d3\u3001\u80c6\u9053\u306a\u3069\uff09\u306e\u9802\u7aef\u819c\u8868\u9762\u306b\u767a\u73fe\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u3053\u306e\u975e\u6a19\u6e96\u7684\u306a\u7d50\u5408\u306f\u3001\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u304c\u30df\u30ea\u30e2\u30eb\u6fc3\u5ea6\u3067\u7d30\u80de\u5185\u306b\u5b89\u5b9a\u3057\u3066\u84c4\u7a4d\u3059\u308b\u305f\u3081\u306b\u4e0d\u53ef\u6b20\u3067\u3059\u3002 <\/p>\n<h3>GSH\u306e\u7d4c\u53e3\u30d0\u30a4\u30aa\u30a2\u30d9\u30a4\u30e9\u30d3\u30ea\u30c6\u30a3\u304c\u4f4e\u3044\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>Intact GSH is poorly absorbed across the intestinal epithelium because: (1) the \u03b3-peptide bond prevents recognition by the standard PEPT1 \/ PEPT2 di-\/tri-peptide transporters that absorb other tripeptides; (2) \u03b3-GT activity at the brush border degrades much of the orally-administered GSH to its constituent amino acids before absorption; (3) the cysteine that is liberated is then largely consumed by enterocyte first-pass GSH re-synthesis. The net oral bioavailability of intact GSH is therefore very low, which is why injectable preparations or N-acetylcysteine (NAC, a cysteine prodrug) are preferred for systemic GSH-boosting studies interventions. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable IV GSH protocol dosing typically uses 600\u20131200 mg per dose, daily or 2\u20133\u00d7\/week, for 4\u201312 weeks in human-subject studies (mirroring the Italian Tationil approved-product dose range of 600\u20132400 mg\/d). Rodent in-vivo work uses 50\u2013150 mg\/kg IV \/ IP, mirroring the dose range that produces reliable systemic GSH elevation despite the short plasma half-life. In-vitro cell-culture protocols typically use 0.5\u201310 mM in growth medium (cells take up cysteine from GSH and re-synthesise intracellular GSH). Users should consult primary literature appropriate to the specific application. <\/p>\n<h3>GSH\u306e\u8840\u6f3f\u4e2d\u534a\u6e1b\u671f\u304c\u975e\u5e38\u306b\u77ed\u3044\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>Plasma \u03b3-GT activity rapidly cleaves the \u03b3-peptide bond of circulating GSH to cysteinylglycine, which is then further cleaved by dipeptidases to cysteine + glycine. The combined \u03b3-GT + dipeptidase cascade gives intact circulating GSH a plasma half-life of only ~10\u201315 minutes. This is why repeated daily dosing is used in clinical-protocols rather than single high-dose bolus regimens, and why N-acetylcysteine (NAC) \u2014 which is taken up intact and used for intracellular GSH synthesis \u2014 is sometimes preferred as a longer-acting cysteine-source alternative for cellular GSH boosting studies. <\/p>\n<h3>Can GSH be combined with B12, NAC, or other redox \/ cofactor compounds in protocols?<\/h3>\n<p>Yes \u2014 GSH is mechanistically connected to many other cellular-redox and cofactor compounds. Common protocol combinations include: GSH + NAC (parallel cysteine-source strategies \u2014 GSH as the intact tripeptide, NAC as the cysteine prodrug \u2014 to compare extracellular vs intracellular GSH-supplementation routes); GSH + <a href=\"https:\/\/medsbase.com\/ja\/b12-cyanocobalamin\/\">\u30d3\u30bf\u30df\u30f3B12<\/a> (oxidative-stress-related neurology and methylation-cycle studies); GSH + <a href=\"https:\/\/medsbase.com\/ja\/nad\/\">NAD\u207a<\/a> \uff08\u7d71\u5408\u7684\u306a\u9178\u5316\u9084\u5143\u30d7\u30fc\u30eb\u306e\u89e3\u6790\uff09\uff1b GSH + <a href=\"https:\/\/medsbase.com\/ja\/ss-31-elamipretide\/\">SS-31<\/a> (mitochondrial-targeted redox studies). Reconstitute each separately just before use and add separately rather than co-storing reconstituted solutions. <\/p>\n<h3>How does this pharmaceutical-grade GSH compare with clinical preparations like Tationil?<\/h3>\n<p>Tationil (and similar branded clinical preparations available in Italy \/ Japan \/ Korea \/ Philippines) is reduced-form L-glutathione approved as a clinical injectable for hepatology and oxidative-stress indications. The pharmaceutical-grade GSH supplied here is the same reduced-form L-glutathione at \u226599% HPLC purity, supplied without a clinical-use label and intended for clinical studies only. Users seeking clinical-use GSH should obtain it through a clinical supply chain; users seeking pharmaceutical-grade material for in-vitro and in-vivo clinical protocols can use the material supplied here. <\/p>\n<h3>GSH\u306fWADA\u7981\u6b62\u30ea\u30b9\u30c8\u306b\u63b2\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u3044\u3044\u3048\u3002\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u306fWADA\u7981\u6b62\u30ea\u30b9\u30c8\u306b\u306f\u63b2\u8f09\u3055\u308c\u3066\u3044\u307e\u305b\u3093\u3002\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\u306f\u3001\u3059\u3079\u3066\u306e\u6709\u6838\u7d30\u80de\u306b\u30df\u30ea\u30e2\u30eb\u6fc3\u5ea6\u3067\u5b58\u5728\u3059\u308b\u5929\u7136\u306e\u7d30\u80de\u5185\u6297\u9178\u5316\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308a\u3001\u3057\u305f\u304c\u3063\u3066\u904b\u52d5\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306b\u95a2\u3059\u308b\u898f\u5236\u306e\u5bfe\u8c61\u3068\u306f\u306a\u308a\u307e\u305b\u3093\u3002 <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/ja\/b12-cyanocobalamin\/\"><strong>B12\uff08\u30b7\u30a2\u30ce\u30b3\u30d0\u30e9\u30df\u30f3\uff09<\/strong><\/a> \u2014 Cobalamin coenzyme \u2014 methylation-cycle companion<\/li>\n<li><a href=\"\/ja\/l-carnitine\/\"><strong>L-\u30ab\u30eb\u30cb\u30c1\u30f3<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/ja\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool \/ electron-transport studies<\/li>\n<li><a href=\"\/ja\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2015 NNMT\u963b\u5bb3\u5264 \u2015 NAD\u8ef8\u524d\u99c6\u4f53\u6e29\u5b58\u3001\u30e1\u30c1\u30eb\u5316\u30d7\u30fc\u30eb\u306e\u7de9\u885d\u4f5c\u7528<\/li>\n<li><a href=\"\/ja\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2015 \u30ab\u30eb\u30b8\u30aa\u30ea\u30d4\u30f3\u7d50\u5408\u6027\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u6a19\u7684\u6297\u9178\u5316\u30da\u30d7\u30c1\u30c9<\/li>\n<li><a href=\"\/ja\/bac-water\/\"><strong>BAC Water\uff08\u9759\u83cc\u6c34\uff09<\/strong><\/a> \u2014 \u5168\u3066\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306e\u518d\u6eb6\u89e3\u306b\u5fc5\u8981 \u2014 \u7121\u83cc\u30010.9%\u30d9\u30f3\u30b8\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u4fdd\u5b58\u5e0c\u91c8\u6db2<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u03b3-\u30b0\u30eb\u30bf\u30df\u30eb\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\uff08\u03b3-Glu-Cys-Gly\uff09\u2014 \u4e3b\u8981\u306a\u7d30\u80de\u5185\u975e\u30bf\u30f3\u30d1\u30af\u8cea\u30c1\u30aa\u30fc\u30eb<br \/>\n\u2705 GPx\u57fa\u8cea\uff08\u904e\u9178\u5316\u7269\u9084\u5143\uff09\uff0bGST\u88dc\u52a9\u57fa\u8cea\uff08\u7570\u7269\u62b1\u5408\uff09\uff0b\u9178\u5316\u9084\u5143\u72b6\u614b\u7de9\u885d<br \/>\n\u2705 \u30e6\u30cb\u30fc\u30af\u306a\u03b3-\u30da\u30d7\u30c1\u30c9\u7d50\u5408 \u2014 \u30da\u30d7\u30c1\u30c0\u30fc\u30bc\u8010\u6027; \u03b3-GT\u306e\u307f\u304c\u5207\u65ad<br \/>\n\u2705 Canonical reference compound for cellular antioxidant defence studies<br \/>\n\u2705 \u51cd\u7d50\u4e7e\u71e5USP\u30b0\u30ec\u30fc\u30c9\u9084\u5143\u578b; CAS 70-18-8, MW 307.32<\/p>\n<p><strong>L-\u30b0\u30eb\u30bf\u30c1\u30aa\u30f3\uff08\u9084\u5143\u578b\/GSH\uff09<\/strong> contains the \u03b3-glutamyl-cysteinyl-glycine tripeptide compound.<\/p>","protected":false},"featured_media":71535,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6517,6516,5737,4442,6519,6494,6518],"class_list":["post-71470","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-antioxidant-peptide","product_tag-glutathione-reduced","product_tag-gsh","product_tag-l-glutathione","product_tag-redox-research","product_tag-research-peptide","product_tag-tripeptide-research-compound","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/71470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=71470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/71535"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=71470"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=71470"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=71470"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=71470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}